Search

everythinglearnresearchcommunity

for

Search:↓

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

Maidenhair fern may help with health issues but should not be used during pregnancy.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Hidradenitis suppurativa, a chronic skin disease, can be managed with antibiotics, lifestyle changes, and in severe cases, surgery. Early diagnosis and careful planning are key, and laser treatment can be an efficient solution for mild to severe cases.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Finasteride improves hair loss in women with hyperandrogenism.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Flutamide reduces hair growth better but has more side effects.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.